<DOC>
	<DOCNO>NCT02866266</DOCNO>
	<brief_summary>Study evaluate impact ER/LA opioid REMS program incidence Emergency Department visit hospitalization overdose/poisoning death among patient prescribe ER/LA opioid analgesic .</brief_summary>
	<brief_title>ER/LA Opioid Surveillance Emergency Department Visits Hospitalizations Overdose Poisoning</brief_title>
	<detailed_description>As part FDA-approved plan evaluate effect REMS program , REMS Program Companies ( RPC ) require submit FDA assessment report regular basis . The present study one several program evaluation component carry support Assessment 5 : Surveillance monitoring misuse , abuse , overdose , addiction , death intervention take . This study evaluate impact ER/LA opioid REMS program incidence ED visit hospitalization overdose/poisoning death among patient prescribe ER/LA opioid analgesic .</detailed_description>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Poisoning</mesh_term>
	<criteria>1 . At least one dispense ER/LA opioid 01 July 2010 2 . At least six month continuous health plan eligibility prior first record dispensing opioid occur included REMS period 1 . Missing implausible value age 2 . Missing implausible value gender</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>